{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:44:47Z","timestamp":1793497487831,"version":"4.5.0"},"reference-count":176,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":1564,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1093\/annonc\/mdv041","type":"journal-article","created":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T05:56:53Z","timestamp":1422943013000},"page":"1604-1620","source":"Crossref","is-referenced-by-count":607,"title":["Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids"],"prefix":"10.1016","volume":"26","author":[{"given":"M.E.","family":"Caplin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ferolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Filosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Garcia-Yuste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Oberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pelosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Perren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.E.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.D.","family":"Travis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlief","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Capdevila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw","family":"Cwikla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"de Herder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Delle Fave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbro","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Falconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Ferone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuhide","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Kaltsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahrettin","family":"Kelestimur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Kianmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Knigge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Kos-Kudla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Krenning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Mitry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Nicolson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dermot","family":"O'Toole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich-Frank","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Pavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ramage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Rindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rockall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Ruszniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Sedlackova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Sundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Toumpanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Vullierme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Wiedenmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Zheng-Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdv041_bb0010","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0b013e3181ec124e","article-title":"The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems","volume":"39","author":"Klimstra","year":"2010","journal-title":"Pancreas"},{"key":"10.1093\/annonc\/mdv041_bb0015","series-title":"Tumours of the Lung, Pleura, Thymus and Heart","author":"Travis","year":"2004"},{"issue":"Suppl","key":"10.1093\/annonc\/mdv041_bb0020","first-page":"S65","article-title":"Neuroendocrine neoplasms of the lung","volume":"116","author":"Cerilli","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/annonc\/mdv041_bb0025","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1309\/AJCP9H1OTMUCSKQW","article-title":"Neuroendocrine carcinomas of the lung: a critical analysis","volume":"131","author":"Moran","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/annonc\/mdv041_bb0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1309\/ETJ3-QBUK-13QD-J8FP","article-title":"Neuroendocrine neoplasia. Current concepts","volume":"113","author":"Wick","year":"2000","journal-title":"Am J Clin Pathol"},{"issue":"Suppl 3","key":"10.1093\/annonc\/mdv041_bb0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000201197","article-title":"Revised classification of neuroendocrine tumors of the lung, pancreas and gut","volume":"55","author":"Capella","year":"1994","journal-title":"Digestion"},{"key":"10.1093\/annonc\/mdv041_bb0040","doi-asserted-by":"crossref","first-page":"545","DOI":"10.5858\/2002-126-0545-PNC","article-title":"Pulmonary neuroendocrine carcinomas. A review of 234 cases and a statistical analysis of 50 cases treated at one institution using a simple clinicopathologic classification","volume":"126","author":"Huang","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1093\/annonc\/mdv041_bb0045","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1097\/JTO.0b013e31818e0dd4","article-title":"Reclassification of neuroendocrine tumors improves the separation of carcinoids and the prediction of survival","volume":"3","author":"Skov","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0050","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.canep.2011.05.011","article-title":"Neuroendocrine tumors: a population-based study of incidence and survival in Girona Province, 1994\u20132004","volume":"35","author":"Alsina","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"10.1093\/annonc\/mdv041_bb0055","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/thx.2007.095067","article-title":"Pulmonary tumors in the Netherlands: focus on temporal trends in histology and stage and on rare tumors","volume":"63","author":"de Jong","year":"2008","journal-title":"Thorax"},{"key":"10.1093\/annonc\/mdv041_bb0060","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1378\/chest.119.6.1647","article-title":"Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature","volume":"119","author":"Fink","year":"2001","journal-title":"Chest"},{"key":"10.1093\/annonc\/mdv041_bb0065","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/14017438909106008","article-title":"Bronchopulmonary carcinoids in Iceland 1955\u20131984. A retrospective clinical and histopathologic study","volume":"23","author":"Hallgrimsson","year":"1989","journal-title":"Scand J Thorac Cardiovasc Surg"},{"key":"10.1093\/annonc\/mdv041_bb0070","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/cncr.23883","article-title":"Neuroendocrine tumor epidemiology: contrasting Norway and North America","volume":"113","author":"Hauso","year":"2008","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0075","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1097-0142(20011015)92:8<2204::AID-CNCR1564>3.0.CO;2-R","article-title":"Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden","volume":"92","author":"Hemminki","year":"2001","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0080","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1054\/bjoc.2000.1394","article-title":"Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974\u201397","volume":"83","author":"Levi","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0085","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0090","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ejcts.2010.08.036","article-title":"Carcinoid lung tumors\u2014incidence, treatment and outcomes: a population-based study","volume":"39","author":"Naalsund","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1093\/annonc\/mdv041_bb0095","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1007\/s00268-005-0774-6","article-title":"7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly","volume":"31","author":"Perez","year":"2007","journal-title":"World J Surg"},{"key":"10.1093\/annonc\/mdv041_bb0100","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1023\/A:1012272314550","article-title":"Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients","volume":"12","author":"Quaedvlieg","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0169-5002(02)00080-6","article-title":"Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in Denmark","volume":"37","author":"Skuladottir","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0110","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u2018carcinoid\u2019: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0115","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ijc.1473","article-title":"Familial carcinoid tumors and subsequent cancers: a nation-wide epidemiologic study from Sweden","volume":"94","author":"Hemminki","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S1470-2045(05)70471-X","article-title":"Survival from rare cancer in adults: a population-based study","volume":"7","author":"Gatta","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y","article-title":"Lung cancer","volume":"75","author":"Travis","year":"1995","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.lungcan.2006.12.001","article-title":"Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening","volume":"56","author":"Carter","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.lungcan.2008.03.012","article-title":"Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: a baseline and two-year repeat study","volume":"62","author":"Pelosi","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/cncr.23542","article-title":"Bronchopulmonary neuroendocrine tumors","volume":"113","author":"Gustafsson","year":"2008","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0145","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/1097-0142(19871115)60:10<2476::AID-CNCR2820601022>3.0.CO;2-R","article-title":"Prognostic factors for gastrointestinal and bronchopulmonary carcinoid tumors","volume":"60","author":"Greenberg","year":"1987","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0150","first-page":"211","article-title":"Bronchopulmonary carcinoids: an analysis of 1,875 reported cases with special reference to a comparison between typical carcinoids and atypical varieties","volume":"5","author":"Soga","year":"1999","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1093\/annonc\/mdv041_bb0155","first-page":"817","article-title":"Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian Epidemiological study: the NET MANAGEMENT study","volume":"35","author":"Faggiano","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"10.1093\/annonc\/mdv041_bb0160","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ijc.23529","article-title":"Risk factors associated with neuroendocrine tumors: a U.S.-based case-control study","volume":"123","author":"Hassan","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1067\/mtc.2002.119886","article-title":"Bronchial carcinoid tumors: surgical management and long-term outcome","volume":"123","author":"Filosso","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1093\/annonc\/mdv041_bb0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1634\/theoncologist.10-2-123","article-title":"Metastatic carcinoid tumors: a clinical review","volume":"10","author":"Zuetenhorst","year":"2005","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/mdv041_bb0175","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.5858\/2003-127-1200-NTCANC","article-title":"Neuroendocrine tumors (carcinoid and neuroendocrine carcinoma) presenting at extra-appendiceal sites in childhood and adolescence","volume":"127","author":"Broaddus","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1093\/annonc\/mdv041_bb0180","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.5858\/2008-132-1079-PAMLTI","article-title":"Primary and metastatic lung tumors in the pediatric population: a review and 25-year experience at a large children's hospital","volume":"132","author":"Dishop","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1093\/annonc\/mdv041_bb0185","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/pbc.20279","article-title":"Primary epithelial lung malignancies in the pediatric population","volume":"45","author":"Lal","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0190","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-0029-1202857","article-title":"Bronchial carcinoid tumors in children: surgical treatment and outcome in a single institution","volume":"19","author":"Rizzardi","year":"2009","journal-title":"Eur J Pediatr Surg"},{"key":"10.1093\/annonc\/mdv041_bb0195","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jpedsurg.2010.02.070","article-title":"Primary lung tumors in children and adolescents: a 90-year experience","volume":"45","author":"Yu","year":"2010","journal-title":"J Pediatr Surg"},{"key":"10.1093\/annonc\/mdv041_bb0200","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.5858\/2009-0583-RAR.1","article-title":"Neuroendocrine tumors of the lung: an update","volume":"134","author":"Rekhtman","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1093\/annonc\/mdv041_bb0205","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International association for the study of lung cancer\/American Thoracic Society\/European Respiratory Society International Multidisciplinary Classification of lung adenocarcinoma","volume":"6","author":"Travis","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0210","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1053\/hupa.2000.19294","article-title":"Pulmonary atypical carcinoid: predictors of survival in 106 cases","volume":"31","author":"Beasley","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1093\/annonc\/mdv041_bb0215","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jtcvs.2006.12.013","article-title":"Initial bronchoscopic treatment for patients with intraluminal bronchial carcinoids","volume":"133","author":"Brokx","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1093\/annonc\/mdv041_bb0220","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2214\/ajr.170.5.9574618","article-title":"Evaluation of primary pulmonary carcinoid tumors using FDG PET","volume":"170","author":"Erasmus","year":"1998","journal-title":"AJR Am J Roentgenol"},{"key":"10.1093\/annonc\/mdv041_bb0225","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000227552","article-title":"Bronchial carcinoids. A review of 22 cases","volume":"53","author":"Froudarakis","year":"1996","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdv041_bb0230","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1096-9098(199610)63:2<99::AID-JSO6>3.0.CO;2-J","article-title":"Carcinoid tumors of the lung: immuno- and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically","volume":"63","author":"Kayser","year":"1996","journal-title":"J Surg Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0235","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1097\/JTO.0b013e318221f54f","article-title":"Tumorlets in familial history of bronchopulmonary carcinoid","volume":"6","author":"De Giorgi","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0240","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1002\/1097-0142(20010601)91:11<2104::AID-CNCR1238>3.0.CO;2-I","article-title":"Familial pulmonary carcinoid tumors","volume":"91","author":"Oliveira","year":"2001","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0245","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1677\/erc.0.0100437","article-title":"Genetics of neuroendocrine and carcinoid tumors","volume":"10","author":"Leotlela","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0250","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/dc.21296","article-title":"Melanocytic bronchopulmonary carcinoid tumor in a patient with multiple endocrine neoplasia syndrome type 1: a case report with emphasis on intraoperative cytological findings","volume":"38","author":"Matsuda","year":"2010","journal-title":"Diagn Cytopathol"},{"key":"10.1093\/annonc\/mdv041_bb0255","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/cncr.20825","article-title":"Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1","volume":"103","author":"Sachithanandan","year":"2005","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0260","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/JTO.0b013e318197f2e7","article-title":"Tumorlets, multicentric carcinoids, lymph-nodal metastases, and long-term behavior in bronchial carcinoids","volume":"4","author":"Ferolla","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0265","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1158\/1078-0432.CCR-07-1631","article-title":"Bronchopulmonary carcinoid: phenotype and long-term outcome in a single-institution series of Italian patients","volume":"14","author":"Rugge","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdv041_bb0270","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/JTO.0b013e31818b06e3","article-title":"The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer","volume":"3","author":"Travis","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0275","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.athoracsur.2013.05.047","article-title":"Recurrence of pulmonary carcinoid tumors after resection: implications for postoperative surveillance","volume":"96","author":"Lou","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1093\/annonc\/mdv041_bb0280","series-title":"Histological Typing of Lung and Pleural Tumors","author":"Travis","year":"1999"},{"key":"10.1093\/annonc\/mdv041_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/ERC-13-0246","article-title":"Grading the neuroendocrine tumors of the lung: an evidence-based proposal","volume":"21","author":"Rindi","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0290","series-title":"Endocrine Pathology","first-page":"261","article-title":"The neuroendocrine lung","author":"Axiotis","year":"2002"},{"key":"10.1093\/annonc\/mdv041_bb0295","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF00199342","article-title":"Revised classification of neuroendocrine tumors of the lung, pancreas and gut","volume":"425","author":"Capella","year":"1995","journal-title":"Virchows Arch"},{"key":"10.1093\/annonc\/mdv041_bb0300","series-title":"Histological Typing of Endocrine Tumors","author":"Solcia","year":"2000"},{"key":"10.1093\/annonc\/mdv041_bb0305","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1165\/rcmb.2012-0027OC","article-title":"Multi-directional differentiation of Ascl1-defined progenitors in lung development and injury repair","volume":"47","author":"Li","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1093\/annonc\/mdv041_bb0310","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/labinvest.3700412","article-title":"Functional facets of the pulmonary neuroendocrine system","volume":"86","author":"Linnoila","year":"2006","journal-title":"Lab Invest"},{"key":"10.1093\/annonc\/mdv041_bb0315","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0925-4773(99)00325-1","article-title":"The molecular basis of lung morphogenesis","volume":"92","author":"Warburton","year":"2000","journal-title":"Mech Dev"},{"key":"10.1093\/annonc\/mdv041_bb0320","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/1097-0142(197710)40:4<1671::AID-CNCR2820400441>3.0.CO;2-O","article-title":"Comparative epidemiology of carcinoid and oat-cell tumors of the lung","volume":"40","author":"Godwin","year":"1977","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0325","series-title":"WHO Classification of Tumors of the Digestive System","author":"Bosman","year":"2010"},{"key":"10.1093\/annonc\/mdv041_bb0330","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0046-8177(98)90047-8","article-title":"Reproducibility of neuroendocrine lung tumor classification","volume":"29","author":"Travis","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1093\/annonc\/mdv041_bb0335","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1309\/AJCPDXFOPXGEF0RP","article-title":"Using the mitosis-specific marker anti-phosphohistone H3 to assess mitosis in pulmonary neuroendocrine carcinomas","volume":"136","author":"Tsuta","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/annonc\/mdv041_bb0340","article-title":"A genomics-based classification of human lung tumors","volume":"5","author":"Clinical Lung Cancer Genome Project (CLCGP)","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1093\/annonc\/mdv041_bb0345","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00428-012-1194-2","article-title":"Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach","volume":"460","author":"Zahel","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1093\/annonc\/mdv041_bb0350","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/01.pas.0000149690.75462.29","article-title":"Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients","volume":"29","author":"Pelosi","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdv041_bb0355","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/JTO.0b013e3181ca063b","article-title":"ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival","volume":"5","author":"Skov","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0360","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/modpathol.2012.81","article-title":"Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors","volume":"25","author":"Walts","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1093\/annonc\/mdv041_bb0365","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fendo.2011.00020","article-title":"Partitioning of bronchopulmonary carcinoids in two different prognostic categories by ki-67 score","volume":"2","author":"Grimaldi","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1093\/annonc\/mdv041_bb0370","series-title":"TNM Classification of Malignant Tumours","author":"Sobin","year":"2010"},{"key":"10.1093\/annonc\/mdv041_bb0375","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","article-title":"TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system","volume":"449","author":"Rindi","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1093\/annonc\/mdv041_bb0380","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/PAS.0b013e318263207c","article-title":"Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods","volume":"36","author":"Tang","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdv041_bb0385","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/0046-8177(95)90221-X","article-title":"Typical and atypical bronchopulmonary carcinoid tumors: a clinicopathologic and KI-67-labeling study","volume":"26","author":"Costes","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1093\/annonc\/mdv041_bb0390","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.humpath.2009.10.030","article-title":"Oncocytic neuroendocrine tumors of the lung: histopathologic spectrum and immunohistochemical analysis of 15 cases","volume":"42","author":"Tsuta","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1093\/annonc\/mdv041_bb0395","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00428-013-1408-2","article-title":"Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids","volume":"462","author":"Warth","year":"2013","journal-title":"Virchows Arch"},{"key":"10.1093\/annonc\/mdv041_bb0400","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/MPA.0b013e3181ec1380","article-title":"NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus)","volume":"39","author":"Phan","year":"2010","journal-title":"Pancreas"},{"key":"10.1093\/annonc\/mdv041_bb0405","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00000478-199506000-00005","article-title":"Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors","volume":"19","author":"Miller","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdv041_bb0410","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1365-2559.2011.03992.x","article-title":"Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)","volume":"59","author":"Gosney","year":"2011","journal-title":"Histopathology"},{"key":"10.1093\/annonc\/mdv041_bb0415","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1164\/ajrccm.185.3.341","article-title":"mTOR\/p70S6K in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia","volume":"185","author":"Rossi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1093\/annonc\/mdv041_bb0420","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1164\/rccm.201010-1685PP","article-title":"Diffuse idiopathic pulmonary neurendocrine cell hyperplasia: a systematic overview","volume":"184","author":"Nassar","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1093\/annonc\/mdv041_bb0425","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.clinimag.2011.11.011","article-title":"What is DIPNECH?","volume":"36","author":"Walker","year":"2012","journal-title":"Clin Imaging"},{"key":"10.1093\/annonc\/mdv041_bb0430","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2214\/AJR.09.3811","article-title":"Spectrum of pulmonary neuroendocrine cell proliferation: diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, tumorlet, and carcinoids","volume":"195","author":"Koo","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1093\/annonc\/mdv041_bb0435","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/PAS.0b013e318158a397","article-title":"Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases","volume":"32","author":"Schmitt","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdv041_bb0440","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00428-011-1118-6","article-title":"Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2","volume":"459","author":"Hermann","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1093\/annonc\/mdv041_bb0445","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-2559.2002.01336.x","article-title":"Neuroendocrine differentiation and prognosis in breast adenocarcinoma","volume":"40","author":"Miremadi","year":"2002","journal-title":"Histopathology"},{"issue":"Suppl 2","key":"10.1093\/annonc\/mdv041_bb0450","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1093\/annonc\/12.suppl_2.S115","article-title":"Clinical significance of neuroendocrine carcinoma of the breast","volume":"12","author":"Sapino","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0455","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/annonc\/mdp334","article-title":"Somatostatin receptor tissue distribution in lung neuroendocrine tumors: a clinicopathologic and immunohistochemical study of 218 \u2018clinically aggressive\u2019 cases","volume":"21","author":"Righi","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0460","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF03345602","article-title":"Biological characterization of neuroendocrine tumors: the role of neuroendocrine markers","volume":"31","author":"Ferolla","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1093\/annonc\/mdv041_bb0465","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/(SICI)1097-0142(19990901)86:5<858::AID-CNCR23>3.0.CO;2-8","article-title":"Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors","volume":"86","author":"Bajetta","year":"1999","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0470","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/bjc.1998.635","article-title":"Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours","volume":"78","author":"Baudin","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0475","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/JTO.0b013e3181861d7b","article-title":"Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007","volume":"3","author":"Lim","year":"2008","journal-title":"J Thorac Oncol"},{"issue":"S7","key":"10.1093\/annonc\/mdv041_bb0480","doi-asserted-by":"crossref","first-page":"vii120","DOI":"10.1093\/annonc\/mds267","article-title":"Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"\u00d6berg","year":"2012","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1093\/annonc\/mdv041_bb0485","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ejcts.2004.05.052","article-title":"Surgical treatment of neuroendocrine tumors of the lung","volume":"26","author":"Daddi","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1093\/annonc\/mdv041_bb0490","doi-asserted-by":"crossref","first-page":"R173","DOI":"10.1677\/ERC-10-0024","article-title":"Paraneoplastic syndromes secondary to neuroendocrine tumours","volume":"17","author":"Kaltsas","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0495","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/annonc\/mdv041_bb0500","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/annonc\/mdv041_bb0505","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1148\/radiographics.22.2.g02mr01351","article-title":"Bronchial carcinoid tumors of the thorax: spectrum of radiologic findings","volume":"22","author":"Jeung","year":"2002","journal-title":"Radiographics"},{"key":"10.1093\/annonc\/mdv041_bb0510","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2214\/AJR.10.5954","article-title":"CT features of peripheral pulmonary carcinoid tumors","volume":"197","author":"Meisinger","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1093\/annonc\/mdv041_bb0515","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.lungcan.2003.08.017","article-title":"Clinical-radiological presentation and outcome of surgically treated pulmonary carcinoid tumors: a long-term single institution experience","volume":"43","author":"Schrevens","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0520","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejcts.2006.11.031","article-title":"Typical and atypical carcinoid: analysis of the experience of the Spanish multicenter study of neuroendocrine tumors of the lung","volume":"31","author":"Garc\u00eda-Yuste","year":"2007","journal-title":"Eur J Cardio Thorac Surg"},{"key":"10.1093\/annonc\/mdv041_bb0525","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00330-012-2615-y","article-title":"Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases","volume":"23","author":"Bhosale","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1093\/annonc\/mdv041_bb0530","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000184855","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological examinations","volume":"90","author":"Sundin","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1093\/annonc\/mdv041_bb0535","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1210\/jc.2008-0459","article-title":"Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy","volume":"93","author":"Leboulleux","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/annonc\/mdv041_bb0540","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00259-009-1349-9","article-title":"(68)Ga-DOTA-NOC PET\/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours","volume":"37","author":"Ambrosini","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1093\/annonc\/mdv041_bb0545","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2265.2003.01931.x","article-title":"Octreoscan in patients with bronchial carcinoid tumors","volume":"59","author":"Granberg","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1093\/annonc\/mdv041_bb0550","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1210\/jc.2010-2022","article-title":"Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (\u226510%) well-differentiated endocrine carcinoma staging","volume":"96","author":"Abgral","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/annonc\/mdv041_bb0555","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1148\/rg.291085126","article-title":"Tumors in the tracheobronchial tree: CT and FDG PET features","volume":"29","author":"Park","year":"2009","journal-title":"Radiographics"},{"key":"10.1093\/annonc\/mdv041_bb0560","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1378\/chest.06-0711","article-title":"The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules","volume":"131","author":"Daniels","year":"2007","journal-title":"Chest"},{"key":"10.1093\/annonc\/mdv041_bb0565","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.7544","article-title":"Test performance of PET-CT for mediastinal lymph node staging of pulmonary carcinoid tumors","volume":"31","author":"Pattenden","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0570","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MNM.0b013e32832999c1","article-title":"68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid","volume":"30","author":"Ambrosini","year":"2009","journal-title":"Nucl Med Commun"},{"key":"10.1093\/annonc\/mdv041_bb0575","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","article-title":"68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT","volume":"48","author":"Gabriel","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1093\/annonc\/mdv041_bb0580","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2967\/jnumed.109.066639","article-title":"A comparison of 68Ga-DOTATATE and 18F-FDG PET\/CT in pulmonary neuroendocrine tumors","volume":"50","author":"Kayani","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1093\/annonc\/mdv041_bb0585","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2967\/jnumed.109.066134","article-title":"The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy","volume":"51","author":"Srirajaskanthan","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1093\/annonc\/mdv041_bb0590","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2967\/jnumed.111.101469","article-title":"Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study","volume":"53","author":"Pfeifer","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1093\/annonc\/mdv041_bb0595","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1210\/jc.2004-1938","article-title":"Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography","volume":"90","author":"Orlefors","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"1 Suppl","key":"10.1093\/annonc\/mdv041_bb0600","doi-asserted-by":"crossref","first-page":"129S","DOI":"10.1378\/chest.123.1_suppl.129S","article-title":"Diagnosis of lung cancer: the guidelines","volume":"123","author":"Rivera","year":"2003","journal-title":"Chest"},{"key":"10.1093\/annonc\/mdv041_bb0605","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/1817-1737.43082","article-title":"Diagnosis of peripheral pulmonary carcinoid tumor using endobronchial ultrasound","volume":"3","author":"Steinfort","year":"2008","journal-title":"Ann Thorac Med"},{"key":"10.1093\/annonc\/mdv041_bb0610","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.athoracsur.2008.04.115","article-title":"Clinical application of direct bronchial ultrasound to visualize and determine endobronchial tumor margins for surgical resection","volume":"86","author":"Sarraf","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1093\/annonc\/mdv041_bb0615","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.suc.2010.07.001","article-title":"Pulmonary assessment for general thoracic surgery","volume":"90","author":"Banki","year":"2010","journal-title":"Surg Clin North Am"},{"key":"10.1093\/annonc\/mdv041_bb0620","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000225947","article-title":"Consensus guidelines for the standards of care in neuroendocrine tumors: echocardiography","volume":"90","author":"Plockinger","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1093\/annonc\/mdv041_bb0625","first-page":"1091","volume":"16","author":"Cheitlin","year":"2003","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1093\/annonc\/mdv041_bb0630","series-title":"International Association for the Study of Lung Cancer Staging Manual in Thoracic Oncology","author":"Goldstraw","year":"2009"},{"key":"10.1093\/annonc\/mdv041_bb0635","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.athoracsur.2009.07.097","article-title":"Management of carcinoid tumors","volume":"89","author":"Detterbeck","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1093\/annonc\/mdv041_bb0640","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jtcvs.2005.05.041","article-title":"The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors","volume":"130","author":"Lim","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1093\/annonc\/mdv041_bb0645","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1477-2574.2010.00198.x","article-title":"Long-term survival after surgical management of neuroendocrine hepatic metastases","volume":"12","author":"Glazer","year":"2010","journal-title":"HPB (Oxford)"},{"key":"10.1093\/annonc\/mdv041_bb0650","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000335597","article-title":"ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary","volume":"95","author":"Pavel","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1093\/annonc\/mdv041_bb0655","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0003-4975(10)64915-6","article-title":"Carcinoid tumors of the lung","volume":"22","author":"Okike","year":"1976","journal-title":"Ann Thorac Surg"},{"key":"10.1093\/annonc\/mdv041_bb0660","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/1010-7940(93)90140-7","article-title":"Diagnosis and treatment of bronchial carcinoid tumors: clinical and pathological review of 120 operated patients","volume":"7","author":"Vadasz","year":"1993","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1093\/annonc\/mdv041_bb0665","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/thx.39.8.617","article-title":"Carcinoid tumours of the bronchus: a 33 year experience","volume":"39","author":"Hurt","year":"1984","journal-title":"Thorax"},{"key":"10.1093\/annonc\/mdv041_bb0670","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/1010-7940(90)90168-Y","article-title":"Low grade neuroendocrine tumors of the lung (bronchial carcinoids)\u201425 years\u2019 experience","volume":"4","author":"Francioni","year":"1990","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1093\/annonc\/mdv041_bb0675","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/1010-7940(90)90140-U","article-title":"Limited and radical resection for tracheal and bronchopulmonary carcinoid tumour. Report on 227 cases","volume":"4","author":"Stamatis","year":"1990","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1093\/annonc\/mdv041_bb0680","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1010-7940(02)00747-9","article-title":"Synchronous bilateral typical pulmonary carcinoid tumors","volume":"23","author":"Beshay","year":"2003","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1093\/annonc\/mdv041_bb0685","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S1010-7940(03)00287-2","article-title":"Synchronous bilateral lung carcinoid tumors: a rare entity?","volume":"24","author":"Spaggiari","year":"2003","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1093\/annonc\/mdv041_bb0690","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ejcts.2006.05.013","article-title":"Metachronous bronchial carcinoid tumor","volume":"30","author":"Rea","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1093\/annonc\/mdv041_bb0695","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1378\/chest.130.5.1405","article-title":"Bronchoscopic cryotherapy treatment of isolated endoluminal typical carcinoid tumor","volume":"130","author":"Bertoletti","year":"2006","journal-title":"Chest"},{"key":"10.1093\/annonc\/mdv041_bb0700","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1378\/chest.94.1.15","article-title":"Nd:YAG laser bronchoscopy. A five-year experience with 1,396 applications in 1,000 patients","volume":"94","author":"Cavaliere","year":"1988","journal-title":"Chest"},{"key":"10.1093\/annonc\/mdv041_bb0705","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.athoracsur.2010.08.062","article-title":"Bronchopulmonary carcinoid tumors: long-term outcomes after resection","volume":"91","author":"Cao","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1093\/annonc\/mdv041_bb0710","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1002\/cncr.24498","article-title":"Pulmonary euroendocrine\/carcinoid tumors: a review article","volume":"115","author":"Bertino","year":"2009","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0715","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000183751","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: biotherapy","volume":"90","author":"Oberg","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1093\/annonc\/mdv041_bb0720","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2036.2009.04174.x","article-title":"Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours","volume":"31","author":"Modlin","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1093\/annonc\/mdv041_bb0725","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1010-7940(02)00055-6","article-title":"Long-term survival of atypical bronchial carcinoids with liver metastases, treated with octreotide","volume":"21","author":"Filosso","year":"2002","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1093\/annonc\/mdv041_bb0730","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0959-8049(01)00073-9","article-title":"Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours","volume":"37","author":"Aparicio","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0735","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1111\/j.1572-0241.2000.03210.x","article-title":"The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors","volume":"95","author":"Ducreux","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1093\/annonc\/mdv041_bb0740","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1200\/JCO.2003.12.142","volume":"21","author":"Faiss","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0745","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group","volume":"27","author":"Rinke","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0750","unstructured":"M Caplin P Ruszniewski M Pavel A randomized, double-blind, placebo-controlled study of lanreotide antiproliferative response in patients with gastroenteropancreatic neuroendocrine tumors (CLARINET). In Paper Presented at The European Cancer Congress, Amsterdam, Netherlands, 27 September\u20131 October 2013."},{"key":"10.1093\/annonc\/mdv041_bb0755","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000111037","article-title":"Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary","volume":"87","author":"Steinm\u00fcller","year":"2008","journal-title":"Neuroendocrinology"},{"key":"10.1093\/annonc\/mdv041_bb0760","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000287255","article-title":"ENETS consensus guidelines for the management of bone and bronchial metastases from neuroendocrine tumors","volume":"91","author":"Kos-Kudla","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1093\/annonc\/mdv041_bb0765","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1023\/A:1011160913619","article-title":"The clinical value of [90Y-DOTA]-d-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II study","volume":"12","author":"Waldherr","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0770","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1200\/JCO.2010.33.7873","article-title":"Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers","volume":"29","author":"Imhof","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0775","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1200\/JCO.2007.15.2553","article-title":"Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate: toxicity, efficacy, and survival","volume":"26","author":"Kwekkeboom","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0780","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00259-006-0355-4","article-title":"Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin","volume":"34","author":"van Essen","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1093\/annonc\/mdv041_bb0785","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1200\/JCO.2005.03.616","article-title":"Phase II\/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281","volume":"23","author":"Sun","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0790","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/1471-2407-9-388","article-title":"Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network","volume":"9","author":"Brizzi","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0795","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00280-006-0306-6","article-title":"Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumors?","volume":"59","author":"Bajetta","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1093\/annonc\/mdv041_bb0800","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000287277","article-title":"ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors","volume":"91","author":"Pavel","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"5 Suppl 2","key":"10.1093\/annonc\/mdv041_bb0805","first-page":"S62","article-title":"Accomplishments in 2008 in the management of gastrointestinal neuroendocrine tumors","volume":"3","author":"Kulke","year":"2009","journal-title":"Gastrointest Cancer Res"},{"issue":"10","key":"10.1093\/annonc\/mdv041_bb0810","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1023\/A:1012569909313","article-title":"Experience in treatment of metastatic pulmonary carcinoid tumors","volume":"12","author":"Granberg","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0815","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/sj.bjc.6605618","article-title":"Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours","volume":"102","author":"Turner","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0820","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ejca.2013.12.011","article-title":"Capecitabine and streptozocin \u00b1 cisplatin in advanced gastroenteropancreatic neuroendocrine tumours","volume":"50","author":"Meyer","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0825","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.lungcan.2003.11.016","article-title":"Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy","volume":"44","author":"Wirth","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0830","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ccr.2005.08.008","article-title":"The Akt-mTOR tango and its relevance to cancer","volume":"8","author":"Hay","year":"2005","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1093\/annonc\/mdv041_bb0835","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdv041_bb0840","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(11)61742-X","article-title":"Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study","volume":"378","author":"Pavel","year":"2011","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdv041_bb0845","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2012.30.15_suppl.4122","article-title":"RAMSETE: a single-arm, multicenter, single-stage phase II trial of RAD001 (everolimus) in advanced and metastatic silent neuro-endocrine tumours in Europe","volume":"30","author":"Pavel","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0850","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib malate for the treatment of pancreatic neuroendocrine tumors","volume":"364","author":"Raymond","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdv041_bb0855","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1200\/JCO.2007.15.9020","article-title":"Activity of sunitinib in patients with advanced neuroendocrine tumors","volume":"26","author":"Kulke","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0860","article-title":"PAZONET: a phase II trial of pazopanib as a sequencing treatment in progressive metastatic neuroendocrine tumors (NETs) patients (pts), on behalf of the Spanish Task Force for NETs (GETNE)","author":"Grande","year":"2012","journal-title":"Paper Presented at ESMO, Vienna"},{"key":"10.1093\/annonc\/mdv041_bb0865","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.2007.13.6374","article-title":"Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0870","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1016\/j.ejca.2013.06.042","article-title":"Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: a phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801)","volume":"49","author":"Castellano","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0875","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1200\/JCO.2011.40.3147","article-title":"Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors","volume":"30","author":"Chan","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv041_bb0880","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1530\/ERC-12-0050","article-title":"Hitting the target: where do molecularly targeted therapies fit in the treatment scheduling of neuroendocrine tumours?","volume":"19","author":"Karpathakis","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"10.1093\/annonc\/mdv041_bb0885","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/14017439009098055","article-title":"Long-term follow-up of classical bronchial carcinoid tumors. Clinicopathologic observations","volume":"24","author":"Warren","year":"1990","journal-title":"Scand J Thorac Cardiovasc Surg"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419318319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419318319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/26\/8\/1604\/5023982\/mdv041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T23:57:42Z","timestamp":1717718262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419318319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":176,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0923753419318319"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdv041","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}